Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

215P - Analysis of factors impacting the outcome in Young Breast Cancers in Low middle-income countries

Date

04 May 2022

Session

Poster Display session

Topics

Survivorship;  Supportive and Palliative Care

Tumour Site

Breast Cancer

Presenters

Priya Iyer

Citation

Annals of Oncology (2022) 33 (suppl_3): S224-S231. 10.1016/annonc/annonc895

Authors

P. Iyer

Author affiliations

  • Cancer Institute Adyar Chennai, Chennai/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 215P

Background

Breast cancer in young adults accounts for 5-6 % of all cancers in this age group. There are very few studies from India evaluating the trend and outcomes of breast cancer in this subgroup. The present study looked at the demographic features, clinical presentation, and outcomes in this group of patients treated at our center.

Methods

Breast cancer patients between the age of 15-30 years with histologically confirmed invasive breast carcinoma treated at our institute from January 2009 to December 2016 were included. Pregnancy-associated breast cancers (PABC) were defined as breast cancer diagnosed either during pregnancy or up to 1-year post-pregnancy in the postpartum period.

Results

Young adult breast cancers were reported in 145 out of 6000 patients (2.41%) diagnosed with breast cancer in the study period. The median age of the patients was 29 years (21-30 years). Stage I, II, III, and IV was observed in 3.4%, 33.7%, 46.2%, and 16.5% of patients respectively. Invasive ductal carcinoma was the most common pathology observed in 126/145 (86.8%) patients, 54.4% (79/145) were ER positive, 25.5% (37/145) Her2 positive, 21.3% (31/145) triple negative, and 24.8% (36/145) had an inconclusive Her2 status. MRM was done in 61.3% (89/145) patients and BCS in 13.1% (19/145). PABC were observed in 32 out of 145 patients (22.06%). Among them, 20/145 (13.8%) were diagnosed with breast cancer in the postpartum period, 10/145 (6.9%) in the third trimester, and 2/145 (1.3%) in the second trimester of pregnancy. The median follow-up was 45 months (1.7-128.1). The 5-year EFS and OS for stage I, II, III and IV was 100%, 74.5%, 47.9% and 0% and 100%, 90.8%, 55.1% and 0% respectively. On univariate and multivariate analysis, stage of the disease and PABC were found to have a significant association with decreased EFS and OS (p< 0.001, p=0.008 and p<0.001, p=0.001 respectively). It was observed that 11/145 (7.5%) of the patients conceived naturally and had a healthy child during the follow-up study.

Conclusions

Breast cancers in young adults are rare but need to be diagnosed at an early stage to improve survival. PABC needs to be managed optimally without delay owing to their aggressive tumor biology. Fertility issues are very pertinent in this group of patients and need special attention.

Legal entity responsible for the study

Cancer Institute Adyar Chennai, Chennai, India.

Funding

Has not received any funding.

Disclosure

The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.